Filter
482
Featured
Recommendations
71
Language
Document type
Fact sheets
129
Videos
87
Guidelines
60
Resource Platforms
57
Studies & Reports
47
Manuals
36
Infographics
21
Strategic & Response Plan
13
Training Material
9
Online Courses
8
Situation Updates
7
No document type
6
Brochures
1
App
1
Countries / Regions
Germany
38
Middle East and North Africa
20
Latin America and the Carribbean
18
Brazil
13
Ukraine
11
Russia
11
Africa
10
Syria
9
Yemen
9
East and Southern Africa
8
West and Central Africa
8
South Africa
6
South Sudan
5
Congo, Democratic Republic of
4
China
4
Mozambique
4
Sudan
4
Angola
4
Global
4
United Kingdom
4
Guinea-Bissau
3
India
3
Lebanon
3
Colombia
3
Mali
2
Philippines
2
Argentina
2
Eastern Europe and Central Asia
2
Western and Central Europe
2
Burkina Faso
1
Sierra Leone
1
Nigeria
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Saudi Arabia
1
Ethiopia
1
Ghana
1
Uganda
1
Niger
1
Somalia
1
Kenya
1
Thailand
1
Indonesia
1
Bangladesh
1
Malawi
1
Ecuador
1
Bolivia
1
Nicaragua
1
Myanmar / Burma
1
South–East Asia Region
1
Canada
1
Kazakhstan
1
Vietnam
1
Gabon
1
Jamaica
1
Tunisia
1
South Korea
1
Belarus
1
French Guyana
1
Authors & Publishers
Publication Years
Category
Countries
126
Women & Child Health
19
Clinical Guidelines
9
Key Resources
8
Capacity Building
7
Pharmacy & Technologies
2
Public Health
1
Version 3 Dec. 2020
The COVID-19 Vaccine Introduction Readiness Assessment Tool (VIRAT)2, developed by WHO in collaboration with PAHO is a tool for the national authorities, that allows for the establishment of a roadmap and to monitor progress in the preparation of the activities related to the in
...
Presentations and agenda of the meeting held to update industry on the COVAX Facility and Gavi’s support for cold chain equipment (CCE) for COVID-19 vaccines.
This issue is available in Engilsh, Maguindanao, Maranao, Tagalog from the website
PhD Martin Moder, österreichischer Molekularbiologe, Autor populärwissenschaftlicher Bücher und Teil der Wissenschaftskabarettgruppe Science Busters, erklärt die Wirkweise und potentiellen Risiken der mRNA-Impfstoffe gegen COVID19
13 July 2021
The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater for this specific group of population using both pass
...
Early data from US biotech Moderna has revealed that its Covid-19 vaccine candidate is 94.5 per cent effective, raising hopes that a range of immunisations will be available to help end the pandemic.
The interim analysis of the vaccine, currently known as mRNA-1273, comes after 95 trial particip
...
In response to the coronavirus disease 2019 (COVID-19) pandemic and the societal disruption it has brought, national governments and the international community have invested billions of dollars and immense amounts of human resources to develop a safe and effective vaccine in an unprecedented time f
...
Immunization in the context of COVID-19 pandemic
recommended
Immunizations are an essential health service that protect susceptible individuals from vaccine-preventable diseases (VPD).2 By providing timely immunizations, individuals and communities remain protected and the likelihood of a VPD outbreak decreases
This publication is available in Arabic, Chines
...
28 Dec 2020. The main objective of these guidelines is to provide tools for staff working in the field of immunization to support effective communication between health personnel and the general population, with the aim of strengthening, maintaining or recovering trust in vaccines and the immunizati
...
Vaccine handling, storage and Transportation of Pfizer BioNTech
COVID-19 COMIRNATY® (Tozinameran)
El propósito de este marco de valores es brindar orientación a nivel mundial acerca de la asignación de las vacunas contra la COVID-19 entre los países y a nivel nacional con respecto a la determinación de los grupos prioritarios para recibirlas dentro de los países, mientras el suministro sea
...
Иммунизация является важной медицинской услугой, которая защищает человечество от болезней, предупреждаемых вакцинацией (БПВ)2. Благодаря своевременной имму
...
Cet article fait partie d’une série d’explications à propos de la mise au point et de la distribution des vaccins.
Available in English, French, Spanisch, Arabic, Chinese and Russian
WHO technical advisory group on behavioural insights and sciences for health, meeting report, 15 October 2020
How do vaccines work to protect us? What are the vaccine technologies in the pipeline and how do we ensure safe vaccines? Dr Katherine O’ Brien explains in Science in 5 !
Guidance for addressing a global infodemic and fostering demand for immunization
December 2020
Misinformation threatens the success of vaccination programs across the world. This guide aims to help organizations to address the global infodemic through the development of strategic and well-coordina
...
This article is part four in a series of explainers on vaccine development and distribution.
Part one focused on how vaccines work to protect our bodies from disease-carrying germs.
Part two focused on the ingredients in a vaccine and the three clinical trial phases.
Part three focused on the ste
...
